SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMY (bristol myers squibb) -- Ignore unavailable to you. Want to Upgrade?


To: DewDiligence_on_SI who wrote (178)4/25/2019 9:05:52 PM
From: zax  Respond to of 194
 
You should check out Celgene's pipeline. Otezla is shaping up to be a monster.



To: DewDiligence_on_SI who wrote (178)4/25/2019 11:49:03 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 194
 
<Eliquis is a monster. Too bad it goes off-patent in 2026.>

Is there any possibility to extend this?